Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890460642> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- W2890460642 abstract "e16032 Background: Current real-world data on patients with metastatic bladder cancer in the community setting are limited. This study describes patient characteristics, health resource utilization (HRU), and costs for this population. Methods: Medical records data from adults diagnosed with stage IV bladder cancer (T4b, node-positive, or distant metastatic disease) between 1/1/2008 and 6/1/2015 were retrospectively collected from a network of 10 US community oncology practices. Patient characteristics, HRU, and costs were assessed. Regression models were used to estimate group effects on utilization and costs through three progression-based lines. Results: Of 508 patients, 75% were male, 79% white, 15% African American, and 71.5% were aged ≥65 years (median age, 71 years; range 35-92 years). Overall, 76.4% were current or past tobacco users. The most prevalent comorbidities were diabetes (23.4%), renal disease (16.5%), and chronic obstructive pulmonary disease (COPD; 12.4%). Overall, 70.1% had distant metastases at diagnosis, including bone (24.0%), lung (23.4%), and liver (14.6%). Of 341 patients analyzed for HRU and cost, 58.9% had hospital visits and 11.7% had emergency department (ED) visits. Age, smoking history, and presence of diabetes were predictors of hospitalization (all P< 0.05). Overall mean monthly total healthcare cost was $18,778 ± $47,006 (median $6285), which was driven by hospitalizations ($14,660 ± 44,686, median $1717). Mean monthly ED cost was $776 ± $5530, median $0. Mean monthly cost for office visits was $186 ± $189, median $152. Procedures in the medical oncology setting had a mean monthly cost of $707 ± $1179, median $395. Other costs included systemic therapy ($267 ± $704, median $117), infused supportive care drugs ($758 ± $1458, median $0), and other drugs ($1422 ± $3745, median $136). Age, presence of diabetes, presence of any comorbidities, body mass index, and impaired composite performance status were predictors of healthcare costs (all P< 0.05). Conclusions: This study showed significant HRU and costs for metastatic bladder cancer patients suggesting high unmet need." @default.
- W2890460642 created "2018-09-27" @default.
- W2890460642 creator A5018449407 @default.
- W2890460642 creator A5032984402 @default.
- W2890460642 creator A5040097028 @default.
- W2890460642 creator A5060973209 @default.
- W2890460642 creator A5086351627 @default.
- W2890460642 date "2017-05-20" @default.
- W2890460642 modified "2023-09-27" @default.
- W2890460642 title "Health resource utilization and costs for stage IV bladder cancer in community oncology settings." @default.
- W2890460642 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.e16032" @default.
- W2890460642 hasPublicationYear "2017" @default.
- W2890460642 type Work @default.
- W2890460642 sameAs 2890460642 @default.
- W2890460642 citedByCount "0" @default.
- W2890460642 crossrefType "journal-article" @default.
- W2890460642 hasAuthorship W2890460642A5018449407 @default.
- W2890460642 hasAuthorship W2890460642A5032984402 @default.
- W2890460642 hasAuthorship W2890460642A5040097028 @default.
- W2890460642 hasAuthorship W2890460642A5060973209 @default.
- W2890460642 hasAuthorship W2890460642A5086351627 @default.
- W2890460642 hasConcept C121608353 @default.
- W2890460642 hasConcept C126322002 @default.
- W2890460642 hasConcept C143998085 @default.
- W2890460642 hasConcept C146357865 @default.
- W2890460642 hasConcept C151730666 @default.
- W2890460642 hasConcept C177713679 @default.
- W2890460642 hasConcept C2780352672 @default.
- W2890460642 hasConcept C3020745361 @default.
- W2890460642 hasConcept C71924100 @default.
- W2890460642 hasConcept C86803240 @default.
- W2890460642 hasConceptScore W2890460642C121608353 @default.
- W2890460642 hasConceptScore W2890460642C126322002 @default.
- W2890460642 hasConceptScore W2890460642C143998085 @default.
- W2890460642 hasConceptScore W2890460642C146357865 @default.
- W2890460642 hasConceptScore W2890460642C151730666 @default.
- W2890460642 hasConceptScore W2890460642C177713679 @default.
- W2890460642 hasConceptScore W2890460642C2780352672 @default.
- W2890460642 hasConceptScore W2890460642C3020745361 @default.
- W2890460642 hasConceptScore W2890460642C71924100 @default.
- W2890460642 hasConceptScore W2890460642C86803240 @default.
- W2890460642 hasLocation W28904606421 @default.
- W2890460642 hasOpenAccess W2890460642 @default.
- W2890460642 hasPrimaryLocation W28904606421 @default.
- W2890460642 isParatext "false" @default.
- W2890460642 isRetracted "false" @default.
- W2890460642 magId "2890460642" @default.
- W2890460642 workType "article" @default.